Chinese General Practice ›› 2024, Vol. 27 ›› Issue (03): 280-285.DOI: 10.12114/j.issn.1007-9572.2023.0306
Special Issue: 女性健康最新文章合辑; 中医最新文章合辑
• Original Research • Previous Articles Next Articles
Received:
2023-06-01
Revised:
2023-08-02
Published:
2024-01-20
Online:
2023-10-23
Contact:
BAI Wenpei
通讯作者:
白文佩
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0306
体检项目 | 基线 | 3年后 | t配对值 | P值 |
---|---|---|---|---|
腰围(cm) | 76.31±7.25 | 77.91±7.62 | -5.120 | <0.001 |
BMI(kg/m2) | 23.2±3.0 | 23.3±3.2 | -0.297 | 0.767 |
UA(μmol/L) | 261.71±48.84 | 279.91±58.11 | -8.916 | <0.001 |
TC(mmol/L) | 4.76±0.59 | 5.01±0.76 | -7.885 | <0.001 |
TG(mmol/L) | 1.02±0.38 | 1.22±0.71 | -6.054 | <0.001 |
FBG(mmol/L) | 5.24±0.56 | 5.16±0.65 | 3.820 | <0.001 |
HDL-C(mmol/L) | 1.49±0.28 | 1.46±0.30 | 0.306 | 0.760 |
LDL-C(mmol/L) | 2.78±0.58 | 2.87±0.68 | -2.072 | 0.039 |
Table 1 Follow-up results of research subjects
体检项目 | 基线 | 3年后 | t配对值 | P值 |
---|---|---|---|---|
腰围(cm) | 76.31±7.25 | 77.91±7.62 | -5.120 | <0.001 |
BMI(kg/m2) | 23.2±3.0 | 23.3±3.2 | -0.297 | 0.767 |
UA(μmol/L) | 261.71±48.84 | 279.91±58.11 | -8.916 | <0.001 |
TC(mmol/L) | 4.76±0.59 | 5.01±0.76 | -7.885 | <0.001 |
TG(mmol/L) | 1.02±0.38 | 1.22±0.71 | -6.054 | <0.001 |
FBG(mmol/L) | 5.24±0.56 | 5.16±0.65 | 3.820 | <0.001 |
HDL-C(mmol/L) | 1.49±0.28 | 1.46±0.30 | 0.306 | 0.760 |
LDL-C(mmol/L) | 2.78±0.58 | 2.87±0.68 | -2.072 | 0.039 |
组别 | 人数 | 腰围(cm) | BMI(kg/m2) | ||||||
---|---|---|---|---|---|---|---|---|---|
基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | ||
未绝经组 | 176 | 75.76±6.78 | 77.62±7.47 | -3.806 | <0.001 | 23.0±2.8 | 23.2±3.1 | -0.755 | 0.451 |
绝经组 | 291 | 76.66±7.53 | 78.09±7.72 | -3.682 | <0.001 | 23.3±3.2 | 23.3±3.2 | 0.357 | 0.722 |
t值 | 1.189 | 0.574 | 0.921 | 0.409 | |||||
P值 | 0.235 | 0.566 | 0.358 | 0.683 |
Table 2 Comparison of waist circumference and BMI between the two groups
组别 | 人数 | 腰围(cm) | BMI(kg/m2) | ||||||
---|---|---|---|---|---|---|---|---|---|
基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | ||
未绝经组 | 176 | 75.76±6.78 | 77.62±7.47 | -3.806 | <0.001 | 23.0±2.8 | 23.2±3.1 | -0.755 | 0.451 |
绝经组 | 291 | 76.66±7.53 | 78.09±7.72 | -3.682 | <0.001 | 23.3±3.2 | 23.3±3.2 | 0.357 | 0.722 |
t值 | 1.189 | 0.574 | 0.921 | 0.409 | |||||
P值 | 0.235 | 0.566 | 0.358 | 0.683 |
组别 | 人数 | UA(μmol/L) | TC(mmol/L) | TG(mmol/L) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | ||
未绝经组 | 176 | 260.09±50.07 | 268.69±58.34 | -2.897 | 0.004 | 4.74±0.58 | 4.85±0.66 | -2.932 | 0.004 | 1.02±0.39 | 1.19±0.55 | -4.836 | <0.001 |
绝经组 | 291 | 262.69±48.13 | 286.69±57.00 | -8.935 | <0.001 | 4.77±0.60 | 5.10±0.79 | -7.543 | <0.001 | 1.02±0.38 | 1.25±0.79 | -4.577 | <0.001 |
t值 | 0.556 | 3.278 | 0.573 | 3.521 | 0.005 | 0.804 | |||||||
P值 | 0.578 | 0.001 | 0.567 | <0.001 | 0.996 | 0.422 | |||||||
组别 | FBG(mmol/L) | HDL-C(mmol/L) | LDL-C(mmol/L) | ||||||||||
基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | ||
未绝经组 | 5.20±0.57 | 5.15±0.65 | 1.213 | 0.227 | 1.47±0.31 | 1.45±0.32 | 0.173 | 0.863 | 2.77±0.58 | 2.76±0.58 | 0.435 | 0.664 | |
绝经组 | 5.26±0.55 | 5.17±0.66 | 1.803 | 0.072 | 1.50±0.27 | 1.47±0.29 | 0.259 | 0.796 | 2.80±0.58 | 2.95±0.73 | -2.881 | 0.005 | |
t值 | 1.132 | 0.283 | 0.787 | 0.740 | 0.423 | 2.823 | |||||||
P值 | 0.258 | 0.777 | 0.432 | 0.460 | 0.672 | 0.005 |
Table 3 Comparison of laboratory examination indexes between the two groups
组别 | 人数 | UA(μmol/L) | TC(mmol/L) | TG(mmol/L) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | ||
未绝经组 | 176 | 260.09±50.07 | 268.69±58.34 | -2.897 | 0.004 | 4.74±0.58 | 4.85±0.66 | -2.932 | 0.004 | 1.02±0.39 | 1.19±0.55 | -4.836 | <0.001 |
绝经组 | 291 | 262.69±48.13 | 286.69±57.00 | -8.935 | <0.001 | 4.77±0.60 | 5.10±0.79 | -7.543 | <0.001 | 1.02±0.38 | 1.25±0.79 | -4.577 | <0.001 |
t值 | 0.556 | 3.278 | 0.573 | 3.521 | 0.005 | 0.804 | |||||||
P值 | 0.578 | 0.001 | 0.567 | <0.001 | 0.996 | 0.422 | |||||||
组别 | FBG(mmol/L) | HDL-C(mmol/L) | LDL-C(mmol/L) | ||||||||||
基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | ||
未绝经组 | 5.20±0.57 | 5.15±0.65 | 1.213 | 0.227 | 1.47±0.31 | 1.45±0.32 | 0.173 | 0.863 | 2.77±0.58 | 2.76±0.58 | 0.435 | 0.664 | |
绝经组 | 5.26±0.55 | 5.17±0.66 | 1.803 | 0.072 | 1.50±0.27 | 1.47±0.29 | 0.259 | 0.796 | 2.80±0.58 | 2.95±0.73 | -2.881 | 0.005 | |
t值 | 1.132 | 0.283 | 0.787 | 0.740 | 0.423 | 2.823 | |||||||
P值 | 0.258 | 0.777 | 0.432 | 0.460 | 0.672 | 0.005 |
组别 | 人数 | CIMT增厚 | 高血压 |
---|---|---|---|
未绝经组 | 176 | 11(6.3) | 9(5.1) |
绝经组 | 291 | 20(6.9) | 32(11.0) |
χ2值 | 0.069 | 4.739 | |
P值 | 0.793 | 0.029 |
Table 4 Comparison of the incidence of increased CIMT and hypertension between the two groups
组别 | 人数 | CIMT增厚 | 高血压 |
---|---|---|---|
未绝经组 | 176 | 11(6.3) | 9(5.1) |
绝经组 | 291 | 20(6.9) | 32(11.0) |
χ2值 | 0.069 | 4.739 | |
P值 | 0.793 | 0.029 |
自变量 | CIMT增厚 | 高血压 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
β | SE | Wald χ2值 | P值 | OR(95%CI) | β | SE | Wald χ2值 | P值 | OR(95%CI) | |
绝经 | 0.258 | 0.441 | 0.343 | 0.558 | 1.295(0.545~3.075) | 0.271 | 0.360 | 0.564 | 0.452 | 1.311(0.647~2.654) |
年龄≥50岁 | 0.906 | 0.438 | 4.285 | 0.038 | 2.475(1.049~5.838) | 0.525 | 0.350 | 2.257 | 0.133 | 1.691(0.852~3.355) |
Table 5 Multivariate Logistic regression analysis of the effect of menopause and age on the incidence of increased CIMT and hypertension in middle-aged women
自变量 | CIMT增厚 | 高血压 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
β | SE | Wald χ2值 | P值 | OR(95%CI) | β | SE | Wald χ2值 | P值 | OR(95%CI) | |
绝经 | 0.258 | 0.441 | 0.343 | 0.558 | 1.295(0.545~3.075) | 0.271 | 0.360 | 0.564 | 0.452 | 1.311(0.647~2.654) |
年龄≥50岁 | 0.906 | 0.438 | 4.285 | 0.038 | 2.475(1.049~5.838) | 0.525 | 0.350 | 2.257 | 0.133 | 1.691(0.852~3.355) |
[1] |
|
[2] |
中华医学会妇产科学分会绝经学组. 中国绝经管理与绝经激素治疗指南2023版[J]. 中华妇产科杂志,2023,58(1):4-21. DOI:10.3760/cma.j.cn112141-20221118-00706.
|
[3] |
|
[4] |
中华医学会心血管病学分会介入心脏病学组,中华医学会心血管病学分会动脉粥样硬化与冠心病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,等. 稳定性冠心病诊断与治疗指南[J]. 中华心血管病杂志,2018,46(9):680-694. DOI:10.3760/cma.j.issn.0253-3758.2018.09.004.
|
[5] |
陈中国,朱晓丽,万宇婷,等. 颈动脉内膜中层厚度与冠心病的相关性分析[J]. 中华介入放射学电子杂志,2019,7(1):31-34. DOI:10.3877/cma.j.issn.2095-5782.2019.01.006.
|
[6] |
罗兰,牛敏,高政南. 中心性肥胖及血糖异常与颈动脉内膜-中层厚度的相关性[J]. 中华糖尿病杂志,2019,11(3):196-200. DOI:10.3760/cma.j.issn.1674-5809.2019.03.007.
|
[7] |
陈波,杨万勇,石新年,等. Hcy、Cyst C、RPB4和颈动脉内膜中层厚度检测在健康体检中预防作用的研讨[J]. 国际医药卫生导报,2020,26(3):314-317. DOI:10.3760/cma.j.issn.1007-1245.2020.03.006.
|
[8] |
国家卫生健康委员会疾病预防控制局,国家心血管病中心,中国医学科学院阜外医院,等. 中国高血压健康管理规范(2019)[J]. 中华心血管病杂志,2020,48(1):10-46. DOI:10.3760/cma.j.issn.0253-3758.2020.01.004.
|
[9] | |
[10] |
中华医学会妇产科学分会绝经学组. 围绝经期异常子宫出血诊断和治疗专家共识[J]. 协和医学杂志,2018,9(4):313-319. DOI:10.3969/j.issn.1674-9081.2018.04.006.
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
张莹,杜鑫,李劼,等. 血清超敏C反应蛋白水平与颈动脉内膜中层厚度的相关性分析[J]. 中国综合临床,2021,37(1):26-30. DOI:10.3760/cma.j.cn101721-20200712-00010.
|
[1] | WU Wenjun, WEI Jingjing, LI Xue, REN Hongjie, YU Rui, PENG Guangcao, ZHU Mingjun. Regularity of Prescriptions for Coronary Heart Disease with Hypertension Based on Latent Structure and Association Rules [J]. Chinese General Practice, 2025, 28(30): 3787-3795. |
[2] | ZHANG Peng, LIU Lidi, ZHANG Ying, YANG Ziyu, LIU Changming, TANG Yijun, LIAO Xiaoyang, JIA Yu. Interpretation and Clinical Implications of the 2024 Italian Guidelines for the Management of Adult Individuals with Overweight and Obesity and Metabolic Comorbidities That are Resistant to Behavioral Treatment [J]. Chinese General Practice, 2025, 28(30): 3747-3752. |
[3] | XU Jialan, YAN Hong, WEN Jun, ZHOU Zitong, WANG Siyu. Prevalence of Potentially Inappropriate Medication in Older Adults with Cancer: a Meta-analysis [J]. Chinese General Practice, 2025, 28(30): 3815-3822. |
[4] | XU Baichuan, WANG Yan, ZHANG Peng, LI Yiting, LIU Feilai, XIE Yang. Research and Analysis of Screening Tools for Chronic Obstructive Pulmonary Disease Comorbidity Lung Cancer [J]. Chinese General Practice, 2025, 28(30): 3847-3852. |
[5] | LI Ling, LI Yaping, QIAN Shixing, NIE Jing, LU Chunhua, LI Xia. Research on Influencing Factors and Risk Prediction of Cognitive Function in Community-dwelling Middle-aged and Elderly People [J]. Chinese General Practice, 2025, 28(30): 3773-3778. |
[6] | ZHOU Qibao, LUO Xiao, CHEN Ling, CAO Junda, LI Juxiang, XU Jinsong, SU Hai. Clinical Study on the Diagnostic Value of Circadian Variability of Systolic Blood Pressure Combined with SDNN in Coronary Heart Disease [J]. Chinese General Practice, 2025, 28(30): 3760-3765. |
[7] | BAI Jiaxin, CHEN Yu, ZHOU Yiheng, LIU Lidi, YANG Rong, YAO Yi, YUAN Bo, ZHANG Yonggang, LEI Yi, ZENG Rui, JIA Yu, LIAO Xiaoyang. Assessment and Treatment of Early-onset Hypertension: Position Statement of the British and Irish Hypertension Association and Its Implications for Clinical Management of Early-onset Hypertension in China [J]. Chinese General Practice, 2025, 28(30): 3741-3746. |
[8] | LU Donglei, YANG Fengying, FENG Zhanpeng, CAO Liquan, TAN Sijie. Conccurent Training Can Improve the Physical Health in Diabesity Individuals: a Meta-analysis [J]. Chinese General Practice, 2025, 28(27): 3410-3421. |
[9] | ZHAO Yuqing, WANG Wei, CHEN Liyuan, YOU Huijuan, WEI Ying, WANG Qinglu, YANG Fengying. Liver Macrophage Polarisation: a New Target for Exercise Prevention and Treatment of Non-alcoholic Fatty Liver Disease [J]. Chinese General Practice, 2025, 28(27): 3456-3465. |
[10] | SHAO Xiaoying, SHAO Jie, ZHU Yan, SHAO Jinling, SHANG Ling, WU Zhenlian, ZHAO Yu, ZHANG Jiacai. Analysis of the Current Status of Iron Deficiency and Factors Affecting Iron Deficiency Anemia among Children Aged 6-36 Months in Guizhou Province [J]. Chinese General Practice, 2025, 28(27): 3368-3374. |
[11] | ZHANG Hongshi, QU Zihan, SUN Xuefeng, WANG Yufeng, CONG Deyu, ZHANG Ye. Effect of Abdominal Massage on Hypothalamus of Insomnia Rats Based on Proteomics [J]. Chinese General Practice, 2025, 28(27): 3399-3409. |
[12] | ZHOU Penglong, CHANG Jing, DING Suying, CHEN Jingfeng, WANG Tao, LI Chenyang. Correlation Analysis between Age-Stratified Differences in Fat-to-muscle Ratio and Hyperuricemia [J]. Chinese General Practice, 2025, 28(27): 3375-3384. |
[13] | QUAN Jialin, ZHU Lin, SU Yu, CHEN Zekai, CHEN Ziqi, ZHANG Zhuofan. Research on the Improvement Effect of Exercise Modes on the Executive Function of Overweight or Obese Children or Adolescents: a Network Meta-analysis [J]. Chinese General Practice, 2025, 28(27): 3422-3431. |
[14] | ZHANG Yunuo, LI Ruibin, WANG Wei. Correlation Analysis of Serum Nesfatin-1 and Ghrelin Levels with Glycolipid Metabolism and Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(26): 3264-3270. |
[15] | CHEN Junyu, HAN Guangli, LI Chunhong, CHEN Yidi, YANG Nana, LUO Xiaoxi. Classification Study of Self-management Types among Pregnant Women in Rural Areas Based on Cluster Analysis [J]. Chinese General Practice, 2025, 28(26): 3289-3293. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||